The new restriction by the NSF, barring 2nd year PhD students from applying for the GRFP, is deeply unfair and ill-timed. My colleague Cindy Reinhart-King weighs in on the news in an AAAS Science article posted today (free access): 👇 www.science.org/content/arti...

🚨 AIMBE calls on the scientific community to urge Congress to ensure timely passage of the FY2026 budget 👇 Strong, sustained funding for our nation's health and science agencies is essential for economic prosperity, U.S. global competitiveness, and public heath. takeaction.io/aimbe/protec...

Protect Research: Finalize FY2026 Budget Now www.congressweb.com/AIMBE/10?fra...

🚨 NEW PAPER ALERT! 🚨 Our new review on “Cellular mechanoactivation of antigen-presenting cells and T cells for cancer immunotherapy” in Current Opinion in Biomedical Engineering! Free #OpenAccess download for all readers! #immunoengineering #mechanobiology www.sciencedirect.com/science/arti...

Amazing! Friend and fellow mechanobiologist Nadeen Chahine was in San Diego and caught a Padres game… and it was Michael King bobblehead night! Thank you so much Nadeen, this is going to look great in my office! 👑⚾️

I made a blog post (“Analyzing Diversity”) on the @springernature.com Communities platform about our new paper in @natmachintell.nature.com ! @natureportfolio.nature.com go.nature.com/4fUysaY

🚨 new paper alert! 🚨 Excited to share our latest paper in @natmachintell.nature.com , we tested 27 large language models to see if any could generate a publication-ready Citation Diversity Report… and several (free) LLMs could! Read paper for free at link: rdcu.be/eCfwJ @natureportfolio.nature.com

This recognition is especially meaningful to me. As a PhD student and postdoc, I had the chance to work with former EIC Prof. Michael King as an assistant editor supporting this journal. Now, I am grateful to current EIC Prof. Ed Sander and the selection committee for this honor.

Our lab’s work is now published in Cellular and Molecular Bioengineering (CMBE) Journal, appearing in the 2025 Young Innovators Issue. I am excited to share it! link.springer.com/article/10.1...

This is extraordinarily dangerous and will slow academic biomedical research and drug development. A total ban is on the horizon. www.drugdiscoverytrends.com/nih-announce...

The line between “no Medicaid for you” and “the only option for access to ‘health care’ if you don’t have insurance is participating in risky, untested interventions” is a short one. Animal models are the bridge from bench to bedside.

Public comment on this new "no animal only studies" is open here: www.fda.gov/news-events/... It closes next Monday.

I'm pleased to announce that CMBE now has an impact factor of 5.0! And don't forget, there's no publishing fee.

AIMBE has launched our new Citizen Advocate for Science Letter: takeaction.io/aimbe/scienc... We ask the broader scientific community to widely share this letter (✍️ <1 minute) with friends, family, and other concerned citizens to urge their elected officials to protect biomedical research funding 👇

I'm pleased to share this nicely done video that captures how special the Rice partnership with the Texas Medical Center is for biomedical researchers... 🔬 🧪 🏙️

Check out this awesome recap story and video on our recent Health Innovations symposium… Thank you to everyone who helped to make this event a great success! @riceenrich.bsky.social news.rice.edu/news/2025/en...

AIMBE has posted a public statement on the impact of federal policy changes on biomedical research: aimbe.org/advocate/wri... Above, we have also developed an advocacy letter for members of the medical & biological engineering community to send to their congressional representatives on this matter.

Funding delays and policy changes are disrupting labs, jeopardizing jobs, and putting the future of science and biomedical engineering at risk. Trainees and early-career researchers are being hit hardest. @aimbe-official.bsky.social is taking action. Read our statement & send a letter to Congress

AIMBE is proud to announce the formation of the Friends of National Institute of Biomedical Imaging and Bioengineering (FoNIBIB) coalition! @friendsofnibib.bsky.social FoNIBIB advocates for NIBIB initiatives by promoting public awareness of its scientific & training programs. friendsofnibib.org

If your institution/organization is interested in joining FoNIBIB, please fill out our interest form here: aimbe.wufoo.com/forms/q1td4w... Follow @friendsofnibib.bsky.social to learn more about coalition activities and NIBIB-related updates. Researchers, your voice is more important now than ever.

We welcome institutions and scientific organizations with a vested interest in medical and biological engineering to join the Friends of NIBIB (FoNIBIB) coalition! We look forward to working with you all to champion the important research and innovations supported by NIBIB. friendsofnibib.org

Registration is now open for AIMBE's Public Policy Institute on October 27-28, 2025 in Washington, DC! Students and trainees in BME can expect 2 days of science and policy training and talks by top Washington insiders. Travel awards are also available! Register now here: aimbe.org/institute

🚨 AIMBE is calling on the biomedical research community to take a minute to send our 3 new advocacy letters urging Congress to: 1. Protect the STEM Training Pipeline (e.g., NIH MOSAIC, T32s, MARC, etc.) 2. Oppose Indirect Cost Caps 3. Support Research Funding in FY2026 aimbe.org/advocate/wri...

What a packed first day of great talks, panel discussions and networking at the Rice—TMC Health Innovations symposia! Truly at the hub of innovations, research and education! Thank you @riceenrich.bsky.social and @profmikeking.bsky.social for hosting and organizing this event!

Aloha brother, welcome to Bluesky! #academicsky #okinawan #uchinanchu

AIMBE is among the 48 societies and nearly 100,000 scientists/experts who recently signed onto @ucsusa.bsky.social's letter calling on Congress to protect the future of science 👇 The full letter is available here: ucs-documents.s3.us-east-1.amazonaws.com/science-netw...

AIMBE is among the 52 societies and organizations who signed onto @aibsbiology.bsky.social's letter to congressional leaders urging them to protect U.S. scientific research and integrity in response to recent executive actions 👇 The full letter is available here: www.aibs.org/assets/colle...

Here's how NIH cuts could jeopardize our life-saving research at Rice University | Opinion www.houstonchronicle.com/opinion/outl...

Join us at the "Health Innovations in the Rice-TMC Ecosystem" symposium for a series of presentations on Innovations in Cancer Research April 24-25 Helix Park's TMC3 Collaborative Building Tickets: bit.ly/3DaBGrR About the event: bit.ly/4kcZP1I

Congratulations to King Lab PhD student Natalie Curry, who won a poster prize at the NCI Tissue Engineering Collaborative Annual Investigators Meeting, for her study on the effect of fluid shear stress on macrophage polarization! Outdoor session in Miami, fun! 🔬☀️

Pub alert for a paper written in collaboration with Mike King's lab where we used focused ultrasound to mechanically stimulate prostate tumor cells in vivo, enhancing apoptosis. Congratulations to our brilliant team members, Abigail Fabiano and Malachy Newman, for their exceptional work!

Excited to share our new paper using Focused Ultrasound to mechanically stimulate prostate tumor cells in vivo, now published in Advanced Science! #OpenAccess Great collab with @cfcaskey.bsky.social Congrats to Abby Fabiano and Malachy Newman 🔊 news.rice.edu/news/2025/ri...

Did you know: your government has 160 million non-expired COVID-19 tests warehoused, and you are entitled to receive 4 more kits shipped to your address free of charge? Just order at: covidtests.gov …they might get destroyed for no good reason, so stock up and be safe

Congratulations to @neuroamyo.bsky.social, one of our inaugural participants in the AIMBE Emerging Leaders Program, on receiving a Sloan Research Fellowship! 🥳

We now have >100 advocates signed up for our #AIMBE2025 Congressional Visits this March 31! Thank you to our Fellows, Emerging Leaders, and other members for making this AIMBE's largest Hill Day to date 💪🔬🧪 Registration for our Annual Event still remains open: annualevent.aimbe.org

AIMBE has developed a new advocacy letter on the changes to NIH indirect cost rates: aimbe.org/advocate/wri... We urge the broader biomedical research community to customize this letter (<1 minute) to contact your congressional representatives about the severe consequences of this new policy 👇

Take action now. NIH’s 15% indirect cost cap threatens research institutions, jobs, and innovation. Customize & send AIMBE’s advocacy letter to urge Congress to stop this harmful policy. Your voice matters!

Thanks Woojin! 😎

Late to the party… start me up, my Bleeps!